Updated February 27, 2008
About the Award
These grants provide elective rotation training opportunities to support learning in advanced areas, techniques, and technologies. The grants are designed to support training that is not fully available in the applicant’s training program. CAP Junior Members are eligible for these awards which are for multiple days up to three months with a maximum amount awarded of up to $2,000 per month.
Examples of new technologies:
- Flow cytometry
- Image analysis
- Flourescense In situ hybridization (FISH)
- Medical informatics
- Microarray Technology
- Molecular diagnostic techniques and applications
The grant funding is intended to support travel and living expenses for the training period, providing adequate time for residents to acquaint themselves with the technology and decide whether they wish to pursue further work in that particular discipline. If necessary, the CAP Foundation Advanced Training Grants may be used for a modest amount of supplies.
The training grants are to support travel within the United States and Canada. Applications will not be funded for training electives which are completed or begun before notification of the award.
It is expected that the recipients’ own institutions will continue to provide for their salaries and benefits during the award period.
Participating Host Institutions and Programs
A sample of host institutions and programs are included in the previous awardee descriptions below. If you would like to contact a previous awardee to learn more about his or her host experience, please contact the Foundation to request the list at 800-323-4040, ext. 7740 or email your request to CAPfdn@cap.org.
Special thanks to the College of American Pathologists, R & D Systems, Chrisope/Remel, Aalto, Abbott Molecular, and US LABS for their generous gifts to support the CAP Foundation Advanced Training Grants.
Funding for projects in molecular pathology and FISH are being supported by an educational grant from Abbott Molecular. Projects for hematopathology are being supported by an educational grant from US Labs and Esoterix.
February 8, 2008 (Note: This deadline has been extended to February 8, 2008.)
October 1, 2008
Applications will be accepted from residents and residents doing fellowships who are still in training and who meet the CAP Junior Member* status.
* Note: Applicants must be a CAP Junior Member or have an application pending.
Please use the Advanced Training Grants application form.
(PDF, 17 KB) (Word, 47 KB)
Applicants are required to submit and/or complete the following information:
- Completed Application Form
- Curriculum Vitae
- Name of their training program, and the name and location of the laboratory in which they wish to pursue training
- Narrative Summary (no more than 500 words)
- Supporting letter from the home institution’s residency program training director or department chair
- Supporting letter from the director of the laboratory at the host institute where the training will take place
Awards are granted on, but not limited to, the following factors:
- Need: technology is not available as needed at the applicant’s institution
- Scientific merit of the application: future use of technology
- Value to the applicant
- Letter of recommendation
Submit applications to:
CAPF Advanced Training Grants
325 Waukegan Road
Northfield, Illinois 60093-2750
For more information about the Advanced Training Grants, please call the CAP Foundation at 800-323-4040 ext. 7740 (in Illinois, 847-832-7740), or send an e-mail to CAPfdn@cap.org.
Past Award Recipients
Julia Braza, MD,
Beth Israel Deaconess Medical Center in Boston Massachusetts.
Visited PhenoPath Lab for a one month training with Dr Allen Gown to explore difficult surgical pathology and hematopathology cases and develop an understanding of how a reference lab is run.
Yumei Chen, MD, PhD,
Ball Memorial Hospital in Muncie Indiana is going to the Medical University of South Carolina.
For a one month training in Hematopathology to learn flow cytometry, cytogenetics, FISH, gene rearrangement and molecular diagnostic techniques.
Ashraf Elnawawi, MD, PhD,
Mt Sinai School of Medicine in New York, is visiting the Brigham and Women’s Hospital.
For a one month training in molecular pathology for neoplastic diseases, and diagnosis for cancers.
Emma Khan, MD,
The University of Kansas Medical Center in Kansas City Kansas, will visit Oregon Health and Science University.
For a one month Hematopathology training to understand 4-color flow cytometry and its application in hematologic disorders.
Alireza Zarineh, MD,
The Allegheny General Hospital in Pittsburgh, Pennsylvania.
Has a one month training in Dermatopathology at the University of Arkansas for Medical Sciences to work on a molecular pathology research project “Cutaneous plasmacytoma associated with Epstein-Barr virus and Human Herpes Virus”.
Essel Dulaimi Al-Saleem, MD
University of Pennsylvania
Dr. Al-Saleem, Drexel University College of Medicine, will study molecular tools in clinical medicine for one month at the University of Pennsylvania.
Soon Bahrami, MD
Dr. Bahrami Indiana University School of Medicine, will study cutaneous hematopathology for one month at Yale University.
Wei Cui, MD
University of Texas
Dr. Cui, University of Kansas Med Center, technology and clinical applicants of real time PCR and PCR hematopathology for one month at the University of Texas.
Atef N. Hanna, MD, PhD
Children’s Hospital, Columbus, OH
Dr. Hanna, University of Tennessee HSC, will study morphological diagnosis of pediatric soft tissue tumors for one month at the Children’s Hospital.
Bharat Thyagarajan, MD
National Cancer Institute
Dr. Thyagarajan, University of Minnesota Medical Center, will study liquid bead array technology for one month at the National Cancer Institute.
Anna K. Wong, MD
Stanford University School of Medicine
Dr. Wong, Cedars- Sinai Medical Center, Los Angeles, will study hematopathology lymph mode and bone marrow sign-outs for one month at the Stanford University School of Medicine.
Ingeborg Fischer MD
New York University Medical Center
Dr. Fischer will train on Molecular Diagnostics in Gliomas —application of molecular pathologic techniques, specifically PCR, FISH, DNA and RNA–Gased microarrays in assessment of brain tumors, including specimen processing, performance of assays and interpretation of results. (The award is funded by the Abbott Molecular)
Monica P. Mosquera–Caro, MD
Cedars-Sinai Medical Center
Dr. Mosquera will train one month at Stanford University School of Medicine in the use of microarray technology for diagnosis, classification and outcome prediction of cutaneous malignancies. (The award is funded by the Abbott Molecular)
Puja Kumari Puri, MD
George Washington University Medical Center
Dr. Puri will train one month at the University of Virginia to train in dermatopathology. (The award is funded by the CAP Foundation)
Marianne Hamel, MD, PhD
Thomas Jefferson University Hospital
Dr. Hamel will train one month at the Office of Chief Medical Examiner, New York City to research forensic neuropathology and forensic cardiac pathology.
Shuko Harada, MD,
Drexel University, College of Medicine, Philadelphia, PA will conduct a one month rotation that will focus exclusively on molecular oncology testing and the institute has a volume of 3100 cases. The resident will learn more about the application of many state-of-art molecular pathology approaches to the diagnosis of neoplasms including PCR (both real time and conventional), FISH/CISH, and microarray technology at Memorial Sloan Kettering, New York. (Abbott Training in Technology Award)
Kun Ru, MD, PhD, England Medical Center, Boston, MA will conduct a one month rotation and learn to screen AML’s with normal cytogenetics, or without common translocations, fusion transcripts, for the presence of molecular abnormalities such as overexpression of WTI and FLT3 length mutations (LM) and to develop quantitative PCR assays of these abnormalities to track MRD at University of Pennsylvania. (Abbott Training in Technology Award)
Marie Peddinghaus, MD, MCP Hahnemann University, Philadelphia, PA, will conduct a one month rotation and gain an insight into the application of molecular pathology in diagnostic decision making at the University of Pennsylvania Health System. (Abbott Training in Technology Award)
Daniel Clayton Zedek, MD, University of North Carolina, Chapel Hill, NC, will conduct a one month rotation where he will conduct research using comparative genomic hybridization, which is a genome wide map to detect DNA sequence number variations at the University of California San Francisco. (Abbott Training in Technology Award)
Jonathan Tobias, MD, University of Cincinnati, studied informatics for one month at the University of Pittsburgh. He worked on a modeling project for caTIES (cancer Text Information Extraction System).
Ibrahim Mansoor, MD, St. John Hosp and Medical Center, studied integrated images in surgical pathology report-analysis of Misys CoPath for one month at Henry Ford Health System.
Lisa G. Swinton McLaughlin, MD, JD, Univ of Kansas Med Center, studied medical informatics and information technology for one month at Henry Ford Hospital.
Marianne Hamel, MD, PhD, Thomas Jefferson Univ Hosp, studied forensic photography and imaging for one month at the Miami-Dade County Medical Examiner.
Anna M. Moran, MD, Hershey Medical Center, studied dermathopathology for one month at the Cleveland Clinic Foundation.
Richard L. Haspel, MD, PhD, Brigham & Women’s Hospital, studied molecular diagnostics in transfusion medicine for one month at the American Red Cross Blood Service, Philadelphia. (Abbott Training in Technology Award)
Fabio R. Tavora, MD, Univ of Maryland Med Ctr, studied vectorette PCR for the rapid identification of t(8:14) in Burkitt lymphoma for two months at John Hopkins Medical Institute. (Abbott Training in Technology Award)
Sameer S. Talwalkar, MD, Univ of Louisville Hosp, studied sequence analysis and quantitative real time PCR (qRT-PCR) using microfluidics technology in chronic lymphocytic leukemia for one month at the Univ of Texas MD Anderson Cancer Center. (Abbott Training in Technology Award)
Samuel K. Caughron, MD, Creighton Univ Med Ctr, studied development of a specific fluorescence in situ hybridization (FISH) probe for the JAK2 gene at 9p24 for one month at Nebraska Medical Center. (Vysis Training in Technology Award)
Deepak Mohan, MD, from the University of Pittsburgh, studied Tissue Microarray FISH and Automated Image Analysis at the University of California.
Luzette K. Habib, MD, from the University of Michigan, studied Public Health Information Network at the LA Public Health Department. (Abbott Training in Technology Award)
Mandana Mahmoodi, MD, from the Drexel University, studied Molecular hematopathology focused on lymphoma at the University of Pittsburgh. (Abbott Training in Technology Award)
Erica Jacobson, MD, from the University of Vermont, studied Molecular Pathology (Hematopathology) at the University of California - Irvine.
David Douglas Grier, MD, from the University of Florida, studied Computer Modeling, Animation and Virtual Reality Techniques for application to Histological Sections at the Bowdoin College,Brunswick Maine.
Zsolt Jobbagy, MD, PhD, Dartmouth Hitchcock Medical Center, studied molecular diagnostics and cytogenetics at the University of North Carolina at Chapel Hill, Chapel Hill, NC. (Abbott Training in Technology Award)
Juan-Miguel Mosquera, MD, Rush-Presbyterian-St. Luke’s Medical Center, studied molecular diagnostic techniques and applications at the National Cancer Institute, Bethesda, MD. (Abbott Training in Technology Award)
Wei Xin, MD, PhD, from the University of Michigan Med. School trained one month on molecular genetic study in pancreatic neoplasia at the Johns Hopkins Medical Institution, Baltimore, MD. (Abbott Training in Technology Award)
Monica E. de Baca, MD, Thomas Jefferson University Hospital trained one month on exposure to clinical & investigative molecular genetics at the University of Pittsburgh Medical Center, Pittsburgh, PA. (Abbott Training in Technology Award)
Marina N. Nikiforova, MD, University of Cincinnati Medical Center, trained one month on real-time quantitative PCR and it’s application for molecular diagnosis at the University of Pittsburgh Medical Center, Pittsburgh, PA. (Abbott Training in Technology Award)
Wei-Qiang Zhao, MD, Tulane University Health Sciences Center, School of Medicine, studied clinical and molecular characterization of soft tissue tumor using comparative genomic hybridization. (Abbott Training in Technology Award)
Neil A. Abrahams, MD, UT MD, Anderson Cancer Center, trained two months in solid tumor cytogenetics, FISH, and molecular diagnostic testing at the University of Nebraska Medical Center. (Abbott Training in Technology Award)
Hunter Hearn, MD, University of Florida, trained one month on Microarray technology at Emory University. (Abbott Training in Technology Award)
Amit Lamba, MD, University of Illinois at Chicago, trained one month on specimen processing, slide preparation, chromosome recognition and FISH hybridization analysis and interpretation at the University of Chicago. (Abbott Training in Technology Award)
Antonio Subtil-DeOliveira, MB, from the Truman Medical Center, studied molecular diagnostic techniques and applications at the University of Graz.
Miroslav Djokic, MD, from the University of Chicago Hospital and Clinics, studied flow cytometry and in its application to the study of detection of residual leukemia and lymphoma at the Royal Marsden Hospital.
Xiu Yan Xie, MD, from the University of Maryland-Baltimore, studied the redox regulation of NF-kB transcriptional activity in pancreatic cancer using a fluorescence image analysis system at the University of Toronto.
Oyedele Adewale Adeyi, MD, from the Dartmouth-Hitchcock Medical Center, studied technical and clinical aspects of Tissue Typing in Relation to Organ Transplantation at the University of Pittsburgh Medical Center.
Michael D. Blechner, MD, from Hartford Hospital, studied pathology informatics and computer-based training at the University of Pittsburgh, School of Medicine.
Wendy W. Liu, MD, PhD, from The Cleveland Clinic Foundation, studied molecular diagnostics in neuromuscular disease at Ohio State University.
Rose Beck, MD, from The Cleveland Clinic Foundation, studied molecular techniques for HLS typing at UCLA Immunogenetics Center.
David Sherman, MD, from Beth Israel Deaconess Medical Center, studied microarray technology at Stanford University.
Maureen Bauer, MD, from the University of North Carolina at Chapel Hill, trained in molecular technology and its applications in patient care at the University of Texas, Health Science Center at San Antonio.
Maria DeTolve Donoghue, DO, from the University of Chicago Hospitals, learned, performed, and optimized molecular hybridizations in immunohistochemistry (IHC), and fluorescence in situ hybridization (FISH) at the Department of Health and Human services, National Institute of Health, Bethesda, Maryland.
Federico Monzon, MD, from Thomas Jefferson University Hospital, studied tissue banking informatics at UPMC Health System, Pittsburgh, Pennsylvania.
Keith Pinkard, MD, PhD, from Washington University School of Medicine, studied forensic DNA analysis for one month at the Forensic Science Research Unit of the Federal Bureau of Investigation.
Marek Skacel, MD, from the Cleveland Clinic Foundation, studied fluorescence in situ hybridization, immunohistochemistry, laser capture microdissection, and tissue microarrays for one month at the National Cancer Institute, Gaithersburg, Maryland.
Stephen Sgan, MD, from Emory University School of Medicine, studied pathogen-inactivation in allogeneic tissue banking for one month at the Community Blood Center/Community Tissues Services in Dayton, Ohio.
Cecilia M. Rosales, MD, from Truman Medical Center, University of Missouri, studied polymerase chain reaction (PCR) methods and would like to expand her knowledge by using reverse transcriptase PCR (RT-PCR) at The University of Texas MD Anderson Cancer Center.
Pratibha S. Shukla, MD, from Danbury Hospital, studied molecular diagnostic techniques and applications at Hartford Hospital.
Jing W. Zhang, MD, PhD, from Tulane University Medical Center, studied molecular diagnostic techniques and applications: Microarray at the National Cancer Institute.
Anuradha M. Dharbhamulla, MD, from Conemaugh Medical Center, studied fine needle aspiration cytology at Magee Womens Hospital.
Jeffrey Goldsmith, MD, from the University of Pennsylvania Medical Center, studied in electron microscopic diagnosis of soft tissue tumors at The Royal Marsden NHS Trust in London.
Anna Wanda Poniecka, MD, from Mount Sinai Medical Center, studied fine needle aspiration with emphasis on image analysis at the University of Texas.
Hunter T. Hardy, MD, from Emory University Hospital, studied LISs and digital imaging at the University of Pittsburgh.
Weidong Huang, MD, PhD, from the University of California at Irvine, studied molecular oncology at the University of Pittsburgh.
Dennis P. O’Malley, MD, from Loma Linda University Medical Center, studied cytogenetics and in situ hybridization at the University of Washington.
Emma Saiz, MD, from Mt. Sinai Medical Center, studied fine needle aspiration at MD Anderson Cancer Center.
Chung-Che Chang, MD, PhD, from (MetroHealth Medical Center, Case Western Reserve University studied molecular diagnostics techniques to detect minimal residual disease in leukemia/lymphomas at Cornell University Medical Center.
Joanna G. Cox, MD, from the Orlando Regional Medical Center, studied molecular immunology at LaJolla Institute for Allergy and Immunology.
Michael W. Riben, MD, from the Albany Medical Center, studied medical informatics at the University of Pittsburgh.
David Zhang, MD, PhD, from Mt. Sinai School of Medicine, Jamaica, New York, studied fine needle aspiration and in situ DNA amplification at MD Anderson Cancer Center.
X.J. (Joseph) Zhou, MD, from the University of California at Irvine College of Medicine, studied molecular diagnostics techniques and applications at the University of Oklahoma.
Mahmood G. Aijazi, MD, from MetroHealth Medical Center, studied medical informatics at the University of Pittsburgh Medical Center.
William M. Taylor, MD, from Rhode Island Hospital, studied in situ hybridization, double immunofluorescence labeling, and confocal microscopy.
Jorge Rios, MD, from Strong Memorial Hospital/University of Rochester, studied immunopathology (flow cytometry, HLA typing) at the Cleveland Clinic.
Lisa A. Spurlock, MD, from St . John Hospital, studied molecular techniques in tumor cytogenetics at Genetrix/SBRI, Inc.
Idris Tolgay Ocal, MD, from Oregon Health Sciences University, studied image analysis and its applications at Montefiore Hospital.
Todd E. Stiles, MD, from the University of Tennessee, studied fine needle aspiration at the MD Anderson Cancer Center.
Basim Al-Khafaji, MD, from the University of Texas, studied fluorescence in situ hybridization at the University of Texas MD Anderson Cancer Center, Houston.
John A. Zebala, MD, from the University of Washington, studied fine needle aspiration at Medical College of Virginia.
Janet E. Roepke, MD, PhD, from Ball Memorial Hospital, studied research and clinical applications of the polymerase chain reaction at Corning Nichols Institute, San Juan Capistrano, California.
Franklin D. R. Montellano, MD, from the University of Illinois at Chicago, studied molecular genetics analysis of tumors in stained histologic slides using microdissection technique at the University of Illinois College of Medicine.
Anne E. Drejet, MD, from California Pacific Medical Center, studied fine needle aspiration at the Karolinski Institute Hospital, Stockholm, Sweden.
Maria L. Evans, MD, from the University of Missouri, developed problem-based software package DXR Clinic for continuing education in pathology at Southern Illinois University School of Medicine.
Galen Mark Kessler, MD, from the Medical College of Pennsylvania, studied applications of the polymerase chain reaction at Georgetown University Medical Center.
Donna M. Skinker, MD, from the University of Kentucky Medical Center, investigated DNA profiling at State Forensic Laboratories.
Carrie L. Phillips, MD, from the National Institute of Health, studied collagen gene expression in lupus nephritis progression at the University of Michigan Medical School.
||Dr. Julia Bridge and Dr. Neil Abrahams performing an in situ hybridization using a Vysis Instruments Hyb machine
| || || |
||Dr. Bridge showing Dr. Abrahams optimal technique for applying probes for an in –situ hybridization.
| || || |
||Dr. Abrahams with all members of Dr. Bridges Molecular Cytogenetic lab. From left to right: Jun Nishio, Neil Abrahams, Stuart Bridge, Jacque Bailey, Pamela Krallman, Julia Bridge and Xao Ming.